Synthon is a company committed to delivering affordable medicines through innovative science. Synthon was founded in 1991, and within two years its creative vision and passion for making health care more aff Read More..
Synthon is a company committed to delivering affordable medicines through innovative science. Synthon was founded in 1991, and within two years its creative vision and passion for making health care more affordable led to the development of its first product. The company is a leading manufacturer and supplier of Anastrozole, Bicalutamide, Exemestane, Ibandronate, Letrozole etc. Its mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, biosimilars and new biological and new chemical entities. The company has headquarters in Netherlands.
Synthon’s ambition is to become a recognized leader in specialty pharmaceuticals, focusing on autoimmune/neurodegenerative diseases, particularly multiple sclerosis (MS) and oncology. Synthon’s strategy from its inception included development of a vertically integrated organization for small molecule generics, controlling every facet of the development chain beginning with the production of raw materials through to manufacture and sale of its products. The products are currently approved by regulatory agencies in over 80 countries worldwide and are marketed through strategic partnerships and in dedicated areas through direct sales.